Brouky Score · 2026

Top VC Firms in China

The 25 highest-scoring venture funds headquartered in China, ranked from 53 eligible firms on a 110-point composite of portfolio outcomes, deal volume, risk adjustment and cheque-size fit.

63
Median score / 110
across eligible firms
53
Eligible firms
5+ tracked investments
1,900
Tracked investments
in this market
25
Firms ranked
highest scoring
Sort by
1

INCE Capital

Series C+China
Industry & HardwareHealthcare & Life SciencesEnergy, Environment & MobilityConsumer, Lifestyle & ServicesArtificial Intelligence & DataSoftware & Developer Tools+3 more
hardwareindustrialmanufacturingautomationdrug-developmentcooling-systems+3 more

INCE Capital focuses on investments in China. They primarily invest in consumer, lifestyle, and services companies at the U stage.

97/ 110Grade A

Investments

17

Portfolio Size

—

Exit Rate

—

Alive

—

Portfolio Status

Not enough tracked outcomes yet

Portfolio Liveness

No alive portfolio to assess

Score Breakdown

Size Fit
15 / 15
Venture Signals
14 / 25
Deal Volume
30 / 30
Portfolio Outcomes
38 / 40
2

Linear Venture

Series C+China
Industry & HardwareSoftware & Developer ToolsHealthcare & Life SciencesEnergy, Environment & MobilityFinance & BlockchainArtificial Intelligence & Data+3 more
aiautomationroboticsenterprise-softwareconstruction-techhardware+3 more

Linear Capital invests in earliest-stage startups applying frontier technologies, focusing on AI software and applications, AI hardware and embodied intelligence, AI for science and manufacturing, energy materials, and biotech, primarily in China.

91/ 110Grade A-

Investments

65

Portfolio Size

—

Exit Rate

—

Alive

—

Portfolio Status

Not enough tracked outcomes yet

Portfolio Liveness

No alive portfolio to assess

Score Breakdown

Size Fit
15 / 15
Venture Signals
9 / 25
Deal Volume
30 / 30
Portfolio Outcomes
37 / 40
3

Cathay Capital

Series C+China
Software & Developer ToolsHealthcare & Life SciencesArtificial Intelligence & DataCommerce & MarketingConsumer, Lifestyle & ServicesFinance & Blockchain+3 more
analyticsdataenterpriseeducationtrainingmachine-learning+3 more

Focuses on early-stage investments in China. Primarily invests in the consumer, lifestyle, and services sectors, targeting B2C companies.

89/ 110Grade A-

Investments

66

Portfolio Size

—

Exit Rate

—

Alive

—

Portfolio Status

Not enough tracked outcomes yet

Portfolio Liveness

No alive portfolio to assess

Score Breakdown

Size Fit
15 / 15
Venture Signals
10 / 25
Deal Volume
30 / 30
Portfolio Outcomes
34 / 40
4

Quan Capital

Series BChina
Healthcare & Life SciencesSoftware & Developer ToolsCommerce & Marketing
healthcaredrug-developmentclinical-stageoncologybiotechpharmaceuticals+3 more

Founded in 2017, Quan Capital is a venture capital firm based in Shanghai, China. The firm prefers to invest in the therapeutic biotech/pharma, enabling technologies/high-end specialty services, and companion diagnostic & precision medicine sectors.

87/ 110Grade A-

Investments

32

Portfolio Size

—

Exit Rate

—

Alive

—

Portfolio Status

Not enough tracked outcomes yet

Portfolio Liveness

No alive portfolio to assess

Score Breakdown

Size Fit
15 / 15
Venture Signals
14 / 25
Deal Volume
30 / 30
Portfolio Outcomes
28 / 40
5

JD.com

Series C+China
Commerce & MarketingIndustry & HardwareConsumer, Lifestyle & ServicesHealthcare & Life Sciences+1 more
consumeradvertisingdigital-advertisingmedia-techout-of-home-advertisingsmart-screens+3 more
86/ 110Grade A-

Investments

14

Portfolio Size

—

Exit Rate

—

Alive

—

Portfolio Status

Not enough tracked outcomes yet

Portfolio Liveness

No alive portfolio to assess

Score Breakdown

Size Fit
15 / 15
Venture Signals
8 / 25
Deal Volume
23 / 30
Portfolio Outcomes
40 / 40
6

Volcanic Ventures

Series AChina
Energy, Environment & MobilityIndustry & HardwareSoftware & Developer ToolsArtificial Intelligence & DataCommerce & MarketingConsumer, Lifestyle & Services+3 more
sustainabilityenvironmenthardwareiotclimate-techai+3 more

Focuses on Series B investments in China. Primarily invests in the Industry & Hardware sector, supporting B2B companies.

84/ 110Grade B+

Investments

30

Portfolio Size

—

Exit Rate

—

Alive

—

Portfolio Status

Not enough tracked outcomes yet

Portfolio Liveness

No alive portfolio to assess

Score Breakdown

Size Fit
15 / 15
Venture Signals
14 / 25
Deal Volume
30 / 30
Portfolio Outcomes
25 / 40
7

Trustbridge Partners

Series C+China
Healthcare & Life SciencesSoftware & Developer ToolsConsumer, Lifestyle & ServicesEnergy, Environment & MobilityIndustry & HardwareCommerce & Marketing+3 more
digital-healthhealthcareeducationanalyticsdatadata-management+3 more

Trustbridge Partners is a growth equity firm focusing on investments in the consumer, healthcare, and technology sectors in China.

84/ 110Grade B+

Investments

14

Portfolio Size

—

Exit Rate

—

Alive

—

Portfolio Status

Not enough tracked outcomes yet

Portfolio Liveness

No alive portfolio to assess

Score Breakdown

Size Fit
15 / 15
Venture Signals
14 / 25
Deal Volume
15 / 30
Portfolio Outcomes
40 / 40
8

Alibaba Group

Series C+China
Software & Developer ToolsIndustry & HardwareCommerce & MarketingConsumer, Lifestyle & ServicesFinance & BlockchainArtificial Intelligence & Data+3 more
aimobile-appcontent-creationconsumercommunityconsumer-tech+3 more

Alibaba Group is a large conglomerate that invests across various sectors, primarily focusing on companies that can benefit from or integrate with its existing e-commerce ecosystem. They target growth-stage companies in sectors like e-commerce, logistics, digital media, and technology, with a strong interest in the Chinese and Indian markets.

80/ 110Grade B

Investments

79

Portfolio Size

—

Exit Rate

—

Alive

—

Portfolio Status

Not enough tracked outcomes yet

Portfolio Liveness

No alive portfolio to assess

Score Breakdown

Size Fit
15 / 15
Venture Signals
1 / 25
Deal Volume
30 / 30
Portfolio Outcomes
34 / 40
9

Shunwei Capital

Series C+China
Industry & HardwareSoftware & Developer ToolsConsumer, Lifestyle & ServicesArtificial Intelligence & DataHealthcare & Life SciencesEnergy, Environment & Mobility+3 more
hardwareconsumercloudiottelecommunicationsautomotive+3 more

Founded in 2011, Shunwei Capital is a venture capital firm based in Beijing, China. The firm seeks to invest in deep technology, smart manufacturing, Internet+, consumption, enterprise services, and the electric-vehicle sectors.

79/ 110Grade B

Investments

71

Portfolio Size

—

Exit Rate

—

Alive

—

Portfolio Status

Not enough tracked outcomes yet

Portfolio Liveness

No alive portfolio to assess

Score Breakdown

Size Fit
15 / 15
Venture Signals
12 / 25
Deal Volume
30 / 30
Portfolio Outcomes
22 / 40
10
Consumer, Lifestyle & ServicesIndustry & HardwareSoftware & Developer ToolsCommerce & MarketingFinance & Blockchain+2 more
saasaiapiembedded-financefinancial-technologyglobal-payments+3 more

Enlight Growth Partners is a China-focused growth capital investor. They target opportunities in supply chain, data, fintech, SaaS and IoT.

78/ 110Grade B-

Investments

42

Portfolio Size

—

Exit Rate

—

Alive

—

Portfolio Status

Not enough tracked outcomes yet

Portfolio Liveness

No alive portfolio to assess

Score Breakdown

Size Fit
15 / 15
Venture Signals
15 / 25
Deal Volume
30 / 30
Portfolio Outcomes
18 / 40
11

Primavera

Series C+China
Consumer, Lifestyle & ServicesHealthcare & Life SciencesIndustry & HardwareEnergy, Environment & MobilitySoftware & Developer ToolsFinance & Blockchain+3 more
r-dsustainabilityaiomnichannelvertical-integrationwomenswear+3 more

Primavera Capital Group is an Asia Pacific-based global investment firm connecting global investors with leading companies in the Asia Pacific region. The firm seeks to develop trusted, lasting partnerships with high-potential growth companies to promote entrepreneurship, fuel innovation, create business value, and have a positive impact on the world.

78/ 110Grade B-

Investments

34

Portfolio Size

—

Exit Rate

—

Alive

—

Portfolio Status

Not enough tracked outcomes yet

Portfolio Liveness

No alive portfolio to assess

Score Breakdown

Size Fit
15 / 15
Venture Signals
14 / 25
Deal Volume
30 / 30
Portfolio Outcomes
19 / 40
12
Software & Developer ToolsIndustry & HardwareHealthcare & Life SciencesEnergy, Environment & Mobility+1 more
enterpriser-dhardwarebiotechdigital-healthcybersecurity+3 more

Focuses on investments in Chinese companies. Primarily invests in the Healthcare & Life Sciences sector, with a preference for later-stage ventures.

78/ 110Grade B-

Investments

18

Portfolio Size

—

Exit Rate

—

Alive

—

Portfolio Status

Not enough tracked outcomes yet

Portfolio Liveness

No alive portfolio to assess

Score Breakdown

Size Fit
15 / 15
Venture Signals
12 / 25
Deal Volume
30 / 30
Portfolio Outcomes
21 / 40
13

Boyu Capital

Series C+China
Healthcare & Life SciencesIndustry & HardwareConsumer, Lifestyle & ServicesSoftware & Developer ToolsCommerce & Marketing+2 more
oncologybiotechdrug-developmentr-dhealthcarepharmaceutical-development+3 more

Boyu Capital focuses on late-stage investments primarily in China, with a key emphasis on healthcare, biotech, technology, and consumer internet sectors. They back growth-stage startups positioned to scale rapidly in these high-potential markets.

77/ 110Grade B-

Investments

23

Portfolio Size

—

Exit Rate

—

Alive

—

Portfolio Status

Not enough tracked outcomes yet

Portfolio Liveness

No alive portfolio to assess

Score Breakdown

Size Fit
15 / 15
Venture Signals
12 / 25
Deal Volume
30 / 30
Portfolio Outcomes
20 / 40
14

CITIC Capital

Series C+China
Industry & HardwareConsumer, Lifestyle & ServicesHealthcare & Life SciencesEnergy, Environment & MobilityCommerce & MarketingSoftware & Developer Tools+3 more
automated-warehouseindustrial-automationintelligent-factorybody-carecosmeticsdiy+3 more

CITIC Capital is a global alternative investment management and advisory company that invests primarily in private equity, real estate, structured investment and finance, special situations, and asset management, focusing on China-related investments.

77/ 110Grade B-

Investments

21

Portfolio Size

—

Exit Rate

—

Alive

—

Portfolio Status

Not enough tracked outcomes yet

Portfolio Liveness

No alive portfolio to assess

Score Breakdown

Size Fit
15 / 15
Venture Signals
14 / 25
Deal Volume
30 / 30
Portfolio Outcomes
18 / 40
15

Legend Capital

Series C+China
Industry & HardwareHealthcare & Life SciencesSoftware & Developer ToolsConsumer, Lifestyle & ServicesFinance & BlockchainArtificial Intelligence & Data+3 more
hardwarer-dbiotechhealthcaresemiconductorgenerative-ai+3 more

Legend Capital invests primarily in growth-stage companies in China, focusing on biotechnology, healthcare, and emerging technologies. They target innovation-driven startups at series-a to series-c-plus stages to support scalable enterprises in B2B and B2C markets.

77/ 110Grade B-

Investments

21

Portfolio Size

—

Exit Rate

—

Alive

—

Portfolio Status

Not enough tracked outcomes yet

Portfolio Liveness

No alive portfolio to assess

Score Breakdown

Size Fit
15 / 15
Venture Signals
10 / 25
Deal Volume
30 / 30
Portfolio Outcomes
22 / 40
16

ZhenFund

Series C+China
Software & Developer ToolsIndustry & HardwareHealthcare & Life SciencesConsumer, Lifestyle & ServicesCommerce & MarketingEnergy, Environment & Mobility+3 more
automationconsumeraiindustrial-automationiotd2c+3 more

ZhenFund focuses on early to growth-stage investments primarily in China, investing in technology, healthcare, and AI sectors. The firm supports startups across B2B, B2C, and B2B2C models, aiming to back visionary entrepreneurs with scalable business potential.

76/ 110Grade B-

Investments

94

Portfolio Size

—

Exit Rate

—

Alive

—

Portfolio Status

Not enough tracked outcomes yet

Portfolio Liveness

No alive portfolio to assess

Score Breakdown

Size Fit
15 / 15
Venture Signals
10 / 25
Deal Volume
30 / 30
Portfolio Outcomes
21 / 40
17

5Y Capital

Series C+China
Software & Developer ToolsConsumer, Lifestyle & ServicesIndustry & HardwareHealthcare & Life SciencesEnergy, Environment & MobilityCommerce & Marketing+3 more
aidatagenerative-aibiotechnologyhealthcareconsumer-tech+3 more

5Y Capital (formerly known as Morningside Ventures) is a venture capital firm that invests in early to growth-stage companies across various sectors, including healthcare, consumer, and technology.

76/ 110Grade B-

Investments

47

Portfolio Size

—

Exit Rate

—

Alive

—

Portfolio Status

Not enough tracked outcomes yet

Portfolio Liveness

No alive portfolio to assess

Score Breakdown

Size Fit
15 / 15
Venture Signals
10 / 25
Deal Volume
30 / 30
Portfolio Outcomes
21 / 40
18

QC Capital

SeedChina
Software & Developer ToolsIndustry & HardwareHealthcare & Life SciencesConsumer, Lifestyle & ServicesFinance & BlockchainCommerce & Marketing+3 more
automationanalyticsapplication-securitycloud-securitythreat-detectionfinance+3 more

Invests in late-stage companies in China. Focuses on the Healthcare & Life Sciences sector.

76/ 110Grade B-

Investments

35

Portfolio Size

—

Exit Rate

—

Alive

—

Portfolio Status

Not enough tracked outcomes yet

Portfolio Liveness

No alive portfolio to assess

Score Breakdown

Size Fit
15 / 15
Venture Signals
10 / 25
Deal Volume
30 / 30
Portfolio Outcomes
21 / 40
19

Baidu Ventures

Corporate VCSeries C+China
Industry & HardwareConsumer, Lifestyle & ServicesSoftware & Developer ToolsHealthcare & Life SciencesArtificial Intelligence & DataEnergy, Environment & Mobility+3 more
digital-healthhealthcarer-dautomotiveaibiotech+3 more

Baidu Ventures (BV) is an independent venture capital firm focusing on artificial intelligence (AI) and deep technology. They invest in early-stage companies with innovative technologies and high growth potential.

74/ 110Grade C+

Investments

26

Portfolio Size

—

Exit Rate

—

Alive

—

Portfolio Status

Not enough tracked outcomes yet

Portfolio Liveness

No alive portfolio to assess

Score Breakdown

Size Fit
15 / 15
Venture Signals
11 / 25
Deal Volume
30 / 30
Portfolio Outcomes
18 / 40
20

Hillhouse Capital

Series C+China
Healthcare & Life SciencesSoftware & Developer ToolsConsumer, Lifestyle & ServicesIndustry & HardwareCommerce & MarketingEnergy, Environment & Mobility+3 more
healthcareconsumereducationd2centerpriser-d+3 more

Focuses on investments in the consumer, lifestyle, and services sectors, primarily in China. They typically invest in companies at the Series F stage.

70/ 110Grade C

Investments

74

Portfolio Size

—

Exit Rate

—

Alive

—

Portfolio Status

Not enough tracked outcomes yet

Portfolio Liveness

No alive portfolio to assess

Score Breakdown

Size Fit
15 / 15
Venture Signals
5 / 25
Deal Volume
30 / 30
Portfolio Outcomes
20 / 40
21

Lilly Asia Ventures

Corporate VCSeries BChina
Healthcare & Life SciencesIndustry & HardwareFinance & BlockchainEnergy, Environment & MobilityConsumer, Lifestyle & Services+2 more
biotechoncologydrug-developmenthealthcarer-dmedical-device+3 more

Focuses on early and growth-stage investments in the healthcare and life sciences sectors across Asia. They target companies with innovative technologies and strong growth potential.

70/ 110Grade C

Investments

38

Portfolio Size

—

Exit Rate

—

Alive

—

Portfolio Status

Not enough tracked outcomes yet

Portfolio Liveness

No alive portfolio to assess

Score Breakdown

Size Fit
15 / 15
Venture Signals
11 / 25
Deal Volume
30 / 30
Portfolio Outcomes
14 / 40
22

Gaorong Capital

Series C+China
Industry & HardwareHealthcare & Life SciencesSoftware & Developer ToolsConsumer, Lifestyle & ServicesCommerce & MarketingEnergy, Environment & Mobility+3 more
roboticsautomationenterprise-softwareconsumerd2cdata-analytics+3 more

Focuses on early-stage investments in the US. Specializes in the Industry & Hardware sector.

67/ 110Grade C-

Investments

23

Portfolio Size

—

Exit Rate

—

Alive

—

Portfolio Status

Not enough tracked outcomes yet

Portfolio Liveness

No alive portfolio to assess

Score Breakdown

Size Fit
15 / 15
Venture Signals
14 / 25
Deal Volume
30 / 30
Portfolio Outcomes
8 / 40
23

Sinovation Ventures

Series BChina
Industry & HardwareConsumer, Lifestyle & ServicesHealthcare & Life SciencesSoftware & Developer ToolsEnergy, Environment & MobilityArtificial Intelligence & Data+3 more
aibiotechnologyautomationhealthcaremanufacturingrobotics+3 more

Sinovation Ventures invests primarily in early and growth-stage AI and technology startups focused on China and global markets, emphasizing innovation in education, healthcare, and frontier technologies to empower the future of artificial intelligence.

67/ 110Grade C-

Investments

15

Portfolio Size

—

Exit Rate

—

Alive

—

Portfolio Status

Not enough tracked outcomes yet

Portfolio Liveness

No alive portfolio to assess

Score Breakdown

Size Fit
15 / 15
Venture Signals
8 / 25
Deal Volume
17 / 30
Portfolio Outcomes
27 / 40
24

Source Code Capital

Series C+China
Industry & HardwareHealthcare & Life SciencesSoftware & Developer ToolsConsumer, Lifestyle & ServicesFinance & BlockchainCommerce & Marketing+3 more
roboticsfinancial-servicesfintechdataautomationmanufacturing+3 more

Focuses on investments in the Industry & Hardware sector, primarily in China. Targets companies in the Series C stage.

66/ 110Grade C-

Investments

106

Portfolio Size

—

Exit Rate

—

Alive

—

Portfolio Status

Not enough tracked outcomes yet

Portfolio Liveness

No alive portfolio to assess

Score Breakdown

Size Fit
15 / 15
Venture Signals
0 / 25
Deal Volume
30 / 30
Portfolio Outcomes
21 / 40
25

Morningside Capital

Series BChina
Healthcare & Life SciencesEnergy, Environment & MobilityConsumer, Lifestyle & ServicesArtificial Intelligence & Data+1 more
healthcaredigital-healthbiotechr-dclinical-stagedrug-development+3 more

Morningside focuses on partnering with innovative companies in technology and healthcare sectors primarily across China and North America, investing in growth-stage rounds to scale global market leaders.

66/ 110Grade C-

Investments

16

Portfolio Size

—

Exit Rate

—

Alive

—

Portfolio Status

Not enough tracked outcomes yet

Portfolio Liveness

No alive portfolio to assess

Score Breakdown

Size Fit
15 / 15
Venture Signals
14 / 25
Deal Volume
30 / 30
Portfolio Outcomes
7 / 40

Methodology

What the score measures, who is eligible, and what it deliberately excludes.

How is the Brouky score for China calculated?
Each firm is scored out of 110 points across four measured components: portfolio outcomes (40), deal volume (30), risk adjustment (25) and cheque-size fit (15). The score is computed from tracked investments and portfolio company status. It is not editorial and firms cannot influence it.
Which firms are eligible for the China ranking?
Venture and corporate venture funds headquartered in China with at least 5 tracked investments. 53 firms qualify; the top 25 are listed. Angel investors, family offices, banks, accelerators and government vehicles are excluded because they are scored on a different basis and are not comparable.
How often is the ranking updated?
Scores are recomputed as new investments and portfolio outcomes are recorded, and this page refreshes daily.
My fund's data looks wrong. Can it be corrected?
Yes. Claim the fund's profile on Brouky to review the underlying investments and portfolio records, and the score updates from the corrected data.

Other rankings

GermanyUnited KingdomFranceNetherlandsSpainSwedenSwitzerlandDenmarkItalyNorwayBelgiumFinlandCzech RepublicIrelandRomaniaPolandLuxembourgAustriaEstoniaPortugalUnited StatesIndiaIsraelSingaporeCanadaAustraliaJapanUnited Arab Emirates